The
Basel-based company's CoaguChek INRange system helps patients and
doctors monitor coagulation and response to Vitamin K Antagonist (VKA)
therapy.
CoaguChek INRange, which includes Bluetooth technology, could offer an
advantage over the current standard of care.
Patients
on VKA therapy usually have to visit the hospital or a doctor's office
for PT/INR testing done with a needle, and then wait up to 2-3 days
for lab results. Roche's system uses a fingerstick and 60-second test
to generate results, the company said in a statement, which could cut
down on lab visits.
No comments:
Post a Comment